Avalo Therapeutics Files 8-K on Security Holder Vote
Ticker: AVTX · Form: 8-K · Filed: Jun 17, 2025 · CIK: 1534120
| Field | Detail |
|---|---|
| Company | Avalo Therapeutics, INC. (AVTX) |
| Form Type | 8-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: AVTX
TL;DR
AVTX is calling a shareholder vote, big decisions ahead.
AI Summary
On June 17, 2025, Avalo Therapeutics, Inc. filed an 8-K report. The filing indicates that the company is submitting matters to a vote of its security holders. No specific details regarding the nature of the vote or the matters to be voted upon were provided in the excerpt.
Why It Matters
This filing signals that Avalo Therapeutics is seeking shareholder approval for a significant decision, which could impact the company's future direction and shareholder value.
Risk Assessment
Risk Level: medium — The filing indicates a vote by security holders, which could lead to significant corporate actions that carry inherent risks.
Key Numbers
- 001-37590 — SEC File Number (Identifies the company's filing with the SEC.)
- 45-0705648 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Avalo Therapeutics, Inc. (company) — Registrant
- June 17, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 450705648 (identifier) — IRS Employer Identification No.
- 1500 Liberty Ridge Drive, Suite 321, Wayne, Pennsylvania 19087 (address) — Principal Executive Offices
- Cerecor Inc. (company) — Former Company Name
FAQ
What specific matters will be presented for a vote by Avalo Therapeutics' security holders?
The provided excerpt does not specify the exact matters to be voted upon by security holders.
When is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 17, 2025.
What is the principal executive office address for Avalo Therapeutics, Inc.?
The principal executive office is located at 1500 Liberty Ridge Drive, Suite 321, Wayne, Pennsylvania 19087.
What was Avalo Therapeutics, Inc. formerly known as?
Avalo Therapeutics, Inc. was formerly known as Cerecor Inc.
Under which section of the Securities Exchange Act is this Current Report filed?
This Current Report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding Avalo Therapeutics, Inc. (AVTX).